Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Pharmacokinetic analysis of [68Ga]Ga-DOTA-TOC PET in meningiomas for assessment of in vivo somatostatin receptor subtype 2.

Bashir A, Vestergaard MB, Binderup T, Broholm H, Marner L, Ziebell M, Fugleholm K, Mathiesen T, Kjær A, Law I.

Eur J Nucl Med Mol Imaging. 2020 Mar 13. doi: 10.1007/s00259-020-04759-1. [Epub ahead of print]

PMID:
32170347
2.

In vivo imaging of cell proliferation in meningioma using 3'-deoxy-3'-[18F]fluorothymidine PET/MRI.

Bashir A, Binderup T, Vestergaard MB, Broholm H, Marner L, Ziebell M, Fugleholm K, Kjær A, Law I.

Eur J Nucl Med Mol Imaging. 2020 Feb 11. doi: 10.1007/s00259-020-04704-2. [Epub ahead of print]

PMID:
32047966
3.

Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis.

Mirian C, Duun-Henriksen AK, Juratli T, Sahm F, Spiegl-Kreinecker S, Peyre M, Biczok A, Tonn JC, Goutagny S, Bertero L, Maier AD, Møller Pedersen M, Law I, Broholm H, Cahill DP, Brastianos P, Poulsgaard L, Fugleholm K, Ziebell M, Munch T, Mathiesen T.

J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):378-387. doi: 10.1136/jnnp-2019-322257. Epub 2020 Feb 10. Review.

PMID:
32041819
4.

[A foreign object in the frontal lobe].

Arum A, Uldum AB, Ziebell M.

Ugeskr Laeger. 2018 Jun 4;180(23). pii: V01180012. Danish.

PMID:
29809125
5.

[Epilepsy surgery].

Pinborg LH, Jespersen B, Beniczky S, Fabricius M, Rasonyi G, Uldall P, Tsiropoulos I, Leffers AM, Madsen C, Foged M, Ziebell M, Henriksen O, Jørgensen M, Vinter K, Stauning L, Broholm H, Brennum J, Sabers A, Rubboli G.

Ugeskr Laeger. 2018 Mar 26;180(13). pii: V09170653. Review. Danish.

PMID:
29587957
6.

The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [123I]FP-CIT SPECT imaging.

Dickson JC, Tossici-Bolt L, Sera T, Booij J, Ziebell M, Morbelli S, Assenbaum-Nan S, Borght TV, Pagani M, Kapucu OL, Hesse S, Van Laere K, Darcourt J, Varrone A, Tatsch K.

EJNMMI Res. 2017 Dec;7(1):10. doi: 10.1186/s13550-016-0253-0. Epub 2017 Jan 24.

7.

Forty years of shunt surgery at Rigshospitalet, Denmark: a retrospective study comparing past and present rates and causes of revision and infection.

Kofoed Månsson P, Johansson S, Ziebell M, Juhler M.

BMJ Open. 2017 Jan 16;7(1):e013389. doi: 10.1136/bmjopen-2016-013389.

8.

Structural characterization of nonactive site, TrkA-selective kinase inhibitors.

Su HP, Rickert K, Burlein C, Narayan K, Bukhtiyarova M, Hurzy DM, Stump CA, Zhang X, Reid J, Krasowska-Zoladek A, Tummala S, Shipman JM, Kornienko M, Lemaire PA, Krosky D, Heller A, Achab A, Chamberlin C, Saradjian P, Sauvagnat B, Yang X, Ziebell MR, Nickbarg E, Sanders JM, Bilodeau MT, Carroll SS, Lumb KJ, Soisson SM, Henze DA, Cooke AJ.

Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):E297-E306. doi: 10.1073/pnas.1611577114. Epub 2016 Dec 30.

9.

Design of Infusion Schemes for Neuroreceptor Imaging: Application to [(11)C]Flumazenil-PET Steady-State Study.

Feng L, Svarer C, Madsen K, Ziebell M, Dyssegaard A, Ettrup A, Hansen HD, Lehel S, Yndgaard S, Paulson OB, Knudsen GM, Pinborg LH.

Biomed Res Int. 2016;2016:9132840. doi: 10.1155/2016/9132840. Epub 2016 Mar 31.

10.

Implementation of the European multicentre database of healthy controls for [(123)I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes.

Albert NL, Unterrainer M, Diemling M, Xiong G, Bartenstein P, Koch W, Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, Kapucu LÖ, Kluge A, Ziebell M, Darcourt J, Nobili F, Pagani M, Sabri O, Hesse S, Borght TV, Van Laere K, Tatsch K, la Fougère C.

Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1315-22. doi: 10.1007/s00259-015-3304-2. Epub 2016 Jan 18.

PMID:
26780619
11.

Acute hypernatremia after voluntary saline intake leading to intracerebral haemorrhage: neuroimaging confirms diagnosis.

Mohtadi A, Gideon P, Ziebell M.

Acta Neurochir (Wien). 2015 Sep;157(8):1321-2. doi: 10.1007/s00701-015-2454-0. Epub 2015 Jun 4. No abstract available.

PMID:
26041668
12.

Extrastriatal binding of [¹²³I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls.

Koch W, Unterrainer M, Xiong G, Bartenstein P, Diemling M, Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, Kapucu OL, Kluge A, Ziebell M, Darcourt J, Nobili F, Pagani M, Hesse S, Vander Borght T, Van Laere K, Tatsch K, la Fougère C.

Eur J Nucl Med Mol Imaging. 2014 Oct;41(10):1938-46. doi: 10.1007/s00259-014-2785-8. Epub 2014 May 8.

PMID:
24806112
13.

Low loss 40 Gbit/s silicon modulator based on interleaved junctions and fabricated on 300 mm SOI wafers.

Marris-Morini D, Baudot C, Fédéli JM, Rasigade G, Vulliet N, Souhaité A, Ziebell M, Rivallin P, Olivier S, Crozat P, Le Roux X, Bouville D, Menezo S, Bœuf F, Vivien L.

Opt Express. 2013 Sep 23;21(19):22471-5. doi: 10.1364/OE.21.022471.

PMID:
24104136
14.

Source localization of rhythmic ictal EEG activity: a study of diagnostic accuracy following STARD criteria.

Beniczky S, Lantz G, Rosenzweig I, Åkeson P, Pedersen B, Pinborg LH, Ziebell M, Jespersen B, Fuglsang-Frederiksen A.

Epilepsia. 2013 Oct;54(10):1743-52. doi: 10.1111/epi.12339. Epub 2013 Aug 14.

15.

Flow-regulated versus differential pressure-regulated shunt valves for adult patients with normal pressure hydrocephalus.

Ziebell M, Wetterslev J, Tisell M, Gluud C, Juhler M.

Cochrane Database Syst Rev. 2013 May 31;(5):CD009706. doi: 10.1002/14651858.CD009706.pub2. Review.

PMID:
23728696
16.

No correlation between body mass index and striatal dopamine transporter availability in healthy volunteers using SPECT and [123I]PE2I.

Thomsen G, Ziebell M, Jensen PS, da Cuhna-Bang S, Knudsen GM, Pinborg LH.

Obesity (Silver Spring). 2013 Sep;21(9):1803-6. doi: 10.1002/oby.20225. Epub 2013 May 21.

17.

No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [123I]FP-CIT (DaTSCAN) and SPECT.

Thomsen G, Knudsen GM, Jensen PS, Ziebell M, Holst KK, Asenbaum S, Booij J, Darcourt J, Dickson JC, Kapucu OL, Nobili F, Sabri O, Sera T, Tatsch K, Tossici-Bolt L, Laere KV, Borght TV, Varrone A, Pagani M, Pinborg LH.

EJNMMI Res. 2013 May 20;3(1):39. doi: 10.1186/2191-219X-3-39.

18.

Striatal dopamine transporter binding does not correlate with clinical severity in dementia with Lewy bodies.

Ziebell M, Andersen BB, Pinborg LH, Knudsen GM, Stokholm J, Thomsen G, Karlsborg M, Høgh P, Mørk ML, Hasselbalch SG.

J Nucl Med. 2013 Jul;54(7):1072-6. doi: 10.2967/jnumed.112.114025. Epub 2013 May 1.

19.

Application of affinity selection-mass spectrometry assays to purification and affinity-based screening of the chemokine receptor CXCR4.

Whitehurst CE, Yao Z, Murphy D, Zhang M, Taremi S, Wojcik L, Strizki JM, Bracken JD, Cheng CC, Yang X, Shipps GW Jr, Ziebell M, Nickbarg E.

Comb Chem High Throughput Screen. 2012 Jul;15(6):473-85.

PMID:
22651846
20.

40 Gbit/s low-loss silicon optical modulator based on a pipin diode.

Ziebell M, Marris-Morini D, Rasigade G, Fédéli JM, Crozat P, Cassan E, Bouville D, Vivien L.

Opt Express. 2012 May 7;20(10):10591-6. doi: 10.1364/OE.20.010591.

PMID:
22565685
21.

Predictive value of dopamine transporter SPECT imaging with [¹²³I]PE2I in patients with subtle parkinsonian symptoms.

Ziebell M, Andersen BB, Thomsen G, Pinborg LH, Karlsborg M, Hasselbalch SG, Knudsen GM.

Eur J Nucl Med Mol Imaging. 2012 Feb;39(2):242-50. doi: 10.1007/s00259-011-1976-9. Epub 2011 Nov 18.

PMID:
22095050
22.

Validation of a method for accurate and highly reproducible quantification of brain dopamine transporter SPECT studies.

Jensen PS, Ziebell M, Skouboe G, Khalid U, de Nijs R, Thomsen G, Knudsen GM, Svarer C.

J Nucl Med Technol. 2011 Dec;39(4):271-8. doi: 10.2967/jnmt.111.090324. Epub 2011 Nov 9.

23.

Ten Gbit/s ring resonator silicon modulator based on interdigitated PN junctions.

Ziebell M, Marris-Morini D, Rasigade G, Crozat P, Fédéli JM, Grosse P, Cassan E, Vivien L.

Opt Express. 2011 Jul 18;19(15):14690-5. doi: 10.1364/OE.19.014690.

PMID:
21934831
24.

Multidimensional profiling of CSF1R screening hits and inhibitors: assessing cellular activity, target residence time, and selectivity in a higher throughput way.

Uitdehaag JC, Sünnen CM, van Doornmalen AM, de Rouw N, Oubrie A, Azevedo R, Ziebell M, Nickbarg E, Karstens WJ, Ruygrok S.

J Biomol Screen. 2011 Oct;16(9):1007-17. doi: 10.1177/1087057111418113. Epub 2011 Aug 26.

PMID:
21873591
25.
26.

High extinction ratio 10 Gbit/s silicon optical modulator.

Rasigade G, Ziebell M, Marris-Morini D, Fédéli JM, Milesi F, Grosse P, Bouville D, Cassan E, Vivien L.

Opt Express. 2011 Mar 28;19(7):5827-32. doi: 10.1364/OE.19.005827.

PMID:
21451607
27.

Analytical model for depletion-based silicon modulator simulation.

Rasigade G, Marris-Morini D, Ziebell M, Cassan E, Vivien L.

Opt Express. 2011 Feb 28;19(5):3919-24. doi: 10.1364/OE.19.003919.

PMID:
21369217
28.

Striatal dopamine transporter binding correlates with serum BDNF levels in patients with striatal dopaminergic neurodegeneration.

Ziebell M, Khalid U, Klein AB, Aznar S, Thomsen G, Jensen P, Knudsen GM.

Neurobiol Aging. 2012 Feb;33(2):428.e1-5. doi: 10.1016/j.neurobiolaging.2010.11.010. Epub 2010 Dec 22.

PMID:
21176997
29.

Experimental determination of the weighting factor for the energy window subtraction-based downscatter correction for I-123 in brain SPECT studies.

de Nijs R, Holm S, Thomsen G, Ziebell M, Svarer C.

J Med Phys. 2010 Oct;35(4):215-22. doi: 10.4103/0971-6203.71765.

30.

Evaluation of in vitro PXR-based assays and in silico modeling approaches for understanding the binding of a structurally diverse set of drugs to PXR.

Xiao L, Nickbarg E, Wang W, Thomas A, Ziebell M, Prosise WW, Lesburg CA, Taremi SS, Gerlach VL, Le HV, Cheng KC.

Biochem Pharmacol. 2011 Mar 1;81(5):669-79. doi: 10.1016/j.bcp.2010.12.003. Epub 2010 Dec 9.

PMID:
21145880
31.

Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I.

Ziebell M, Holm-Hansen S, Thomsen G, Wagner A, Jensen P, Pinborg LH, Knudsen GM.

J Nucl Med. 2010 Dec;51(12):1885-91. doi: 10.2967/jnumed.110.078337. Epub 2010 Nov 15. Erratum in: J Nucl Med. 2011 Jan;52(1):106.

32.

[Lewy body dementia].

Ziebell M, Korbo L, Hasselbalch SG.

Ugeskr Laeger. 2010 May 31;172(22):1675-8. Danish.

PMID:
20525466
33.

MRI-guided region-of-interest delineation is comparable to manual delineation in dopamine transporter SPECT quantification in patients: a reproducibility study.

Ziebell M, Pinborg LH, Thomsen G, de Nijs R, Svarer C, Wagner A, Knudsen GM.

J Nucl Med Technol. 2010 Jun;38(2):61-8. doi: 10.2967/jnmt.109.072801. Epub 2010 May 18.

34.

[(3)H]chlorpromazine photolabeling of the torpedo nicotinic acetylcholine receptor identifies two state-dependent binding sites in the ion channel.

Chiara DC, Hamouda AK, Ziebell MR, Mejia LA, Garcia G 3rd, Cohen JB.

Biochemistry. 2009 Oct 27;48(42):10066-77. doi: 10.1021/bi901271w.

35.

The relationship between physical performance and self-perception in children with and without cerebral palsy.

Ziebell M, Imms C, Froude EH, McCoy A, Galea M.

Aust Occup Ther J. 2009 Feb;56(1):24-32. doi: 10.1111/j.1440-1630.2008.00775.x. Erratum in: Aust Occup Ther J. 2009 Jun;56(3):218.

PMID:
20854486
36.

Affinity selection-mass spectrometry screening techniques for small molecule drug discovery.

Annis DA, Nickbarg E, Yang X, Ziebell MR, Whitehurst CE.

Curr Opin Chem Biol. 2007 Oct;11(5):518-26. Epub 2007 Oct 10. Review.

PMID:
17931956
37.

[123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference region.

Pinborg LH, Videbaek C, Ziebell M, Mackeprang T, Friberg L, Rasmussen H, Knudsen GM, Glenthoj BY.

Neuroimage. 2007 Feb 15;34(4):1450-3. Epub 2006 Dec 18.

PMID:
17175177
38.

Reproducibility of [123I]PE2I binding to dopamine transporters with SPECT.

Ziebell M, Thomsen G, Knudsen GM, de Nijs R, Svarer C, Wagner A, Pinborg LH.

Eur J Nucl Med Mol Imaging. 2007 Jan;34(1):101-9. Epub 2006 Jul 29.

PMID:
16896668
39.

Discovery and characterization of orthosteric and allosteric muscarinic M2 acetylcholine receptor ligands by affinity selection-mass spectrometry.

Whitehurst CE, Nazef N, Annis DA, Hou Y, Murphy DM, Spacciapoli P, Yao Z, Ziebell MR, Cheng CC, Shipps GW Jr, Felsch JS, Lau D, Nash HM.

J Biomol Screen. 2006 Mar;11(2):194-207. Epub 2006 Feb 20.

PMID:
16490772
40.

Photolabeling the Torpedo nicotinic acetylcholine receptor with 4-azido-2,3,5,6-tetrafluorobenzoylcholine, a partial agonist.

Nirthanan S, Ziebell MR, Chiara DC, Hong F, Cohen JB.

Biochemistry. 2005 Oct 18;44(41):13447-56.

PMID:
16216068
41.

Quantification of 123I-PE2I binding to dopamine transporter with SPECT after bolus and bolus/infusion.

Pinborg LH, Ziebell M, Frøkjaer VG, de Nijs R, Svarer C, Haugbøl S, Yndgaard S, Knudsen GM.

J Nucl Med. 2005 Jul;46(7):1119-27.

42.

Interactions of peptide mimics of hyaluronic acid with the receptor for hyaluronan mediated motility (RHAMM).

Ziebell MR, Prestwich GD.

J Comput Aided Mol Des. 2004 Oct;18(10):597-614.

PMID:
15849992
43.

Cognitive and functional neuroimaging correlate for anosognosia in mild cognitive impairment and Alzheimer's disease.

Vogel A, Hasselbalch SG, Gade A, Ziebell M, Waldemar G.

Int J Geriatr Psychiatry. 2005 Mar;20(3):238-46.

PMID:
15717342
44.

Identification of binding sites in the nicotinic acetylcholine receptor for [3H]azietomidate, a photoactivatable general anesthetic.

Ziebell MR, Nirthanan S, Husain SS, Miller KW, Cohen JB.

J Biol Chem. 2004 Apr 23;279(17):17640-9. Epub 2004 Feb 3.

45.

2-(3-Methyl-3H-diaziren-3-yl)ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate: a derivative of the stereoselective general anesthetic etomidate for photolabeling ligand-gated ion channels.

Husain SS, Ziebell MR, Ruesch D, Hong F, Arevalo E, Kosterlitz JA, Olsen RW, Forman SA, Cohen JB, Miller KW.

J Med Chem. 2003 Mar 27;46(7):1257-65.

PMID:
12646036
47.

Peptides that mimic glycosaminoglycans: high-affinity ligands for a hyaluronan binding domain.

Ziebell MR, Zhao ZG, Luo B, Luo Y, Turley EA, Prestwich GD.

Chem Biol. 2001 Nov;8(11):1081-94.

48.

A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells.

Luo Y, Ziebell MR, Prestwich GD.

Biomacromolecules. 2000 Summer;1(2):208-18.

PMID:
11710102
49.

Control of enzymatic degradation of hyaluronan by divalent cations.

Vercruysse KP, Ziebell MR, Prestwich GD.

Carbohydr Res. 1999 May 31;318(1-4):26-37.

PMID:
10515049
50.

Rapid hyaluronan uptake is associated with enhanced motility: implications for an intracellular mode of action.

Collis L, Hall C, Lange L, Ziebell M, Prestwich R, Turley EA.

FEBS Lett. 1998 Dec 4;440(3):444-9.

Supplemental Content

Loading ...
Support Center